21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Crystalline drug form
#25202Treatment of hypertension
#25203Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
#25204Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
#25205Biologically active complex
#25206Medical use for tachykinin antagonists
#25207Composition containing moutan root bark extract as active ingredient
#25208Pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof
#25209Natural product based apoptosis inducers
#25210Antioxidant and antiactinic tea plant products
#25211Method for potentiating activity of a chemotherapeutic drug
#25212Combination drug therapy for reducing scar tissue formation
#25213Therapeutic agent for a cancer and method of screening the same, and health-care auxillary food
#25214Growth promoter composition for animals
#25215Boroproline compound combination therapy
#25216Methods of preventing or treating disorders by administering and integrin alphanubeta3 antagonist in combination with an HMG-CoA reductase inhibitor or a bisphosphonate
#25217Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
#25218Treatment of acne by topical herbal extract solution
#25219Compositions and methods for cleaning nasal cavities
#25220Anti-viral compounds
#25221Gamma-tocopherol and gamma-tocotrienol therapy for multiple sclerosis
#25222Methods and kits for treating depression or preventing deterioration of cognitive function
#25223Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damage
#25224Compositions of a cyclooxygenase-2 selective inhibitor and an angiotensin II receptor antagonist for the treatment of central nervous system damage
#25225Treatment methods
#25226Anticancer agent
#25227Breast cancer treatment regimen
#25228Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
#25229Ophthalmic formulations including selective alpha 1 antagonists
#25230Anti-asthmatic combinations comprising surface active phospholipids
#25231Charged phospholipid compositions and methods for their use
#25232Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
#25233Vaginal pharmaceutical compositions and methods for preparing them
#25234Methods for treating acute and overuse sprain and strain using hyaluronic acid
#25235Use of BVDU for inhibiting the growth of hyperproliferative cells
#25236Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#25237Stabilization of pharmaceutical protein formulations with small peptides
#25238Antithrombotic materials and methods
#25239ApO2 ligand/TRAIL formulations
#25240Compositions and methods for modulating serum cholesterol
#25241Antimicrobial composition
#25242Receptor recognition factors, protein sequences and methods of use thereof
#25243Use of a polyphenol for the treatment of actinic keratosis
#25244Compositions comprising herbs and method for immunomodulation
#25245Clear, stable topical compositions of clarithromycin and processes for their preparation
#25246Methods and therapeutic compositions in the treatment of advanced cancer
#25247Inhibitor of cardiac tachyarrhythmias
#25248Methods and compositions for immunotherapy of B cell involvement in promotion of a disease condition comprising multiple sclerosis
#25249Methods and compositions for inducing apoptosis in cancer cells
#25250Solubilized CoQ-10 and carnitine
#25251Method for improving oxygen transport by stored red blood cells
#25252Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof
#25253Combination bacteriolytic therapy for the treatment of tumors
#25254Method of treating endometreosis
#25255Methods for enhancing immune functions in neonatal mammals by administration of IL-18
#25256Toothpaste formulation with green tea extract and fluoride
#25257Minoxidil pharmaceutical foam formulation
#25258Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia
#25259Nitric oxide donor composition and method for treatment of anal disorders
#25260Methods for treating IGF1R-inhibitor induced hyperglycemia
#25261Benzimidazole derivatives as modulators of IgE
#25262Compositions of a cyclooxygenase-2 selective inhibitor and an IKK inhibitor for the treatment of ischemic mediated central nervous system disorders or injury
#25263Compositions and methods for treating or preventing convulsions or seizures
#25264Neurological disorder treatment methods
#25265Ophthalmic compositions containing galactomannan polymers and borate
#25266Gangliosides with a modified acyl function
#25267Pharmaceutical preparation with RNA as hemostasis cofactor
#25268Injectable compositions for the controlled delivery of pharmacologically active compound
#25269Combination comprising combretastatin and anticancer agents
#25270Materials and methods for inhibiting the development of epilepsy
#25271Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
#25272Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses
#25273Methods and products related to metabolic interactions in disease
#25274Induction of tubular morphogenesis using pleiotrophin
#25275Biologically stable liquid composition of FVIII, of vWF or of FVIII/vWF complex of human origin
#25276Factor VII polypeptide having factor VII:C activity
#25277Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity
#25278Method and composition for treating a biological sample
#25279Topical preparations for use in treatment of anorectal disease
#25280Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
#25281Polyherbal formulation for hepatic and splenic disorders
#25282Calcium zeolite hemostatic agent
#25283Bilious balsam
#25284Apparatus and method for administering a therapeutic agent into tissue
#25285Device for regeneration of articular cartilage and other tissue
#25286Supression of allergic reactions by transdermal administration of allergens conjugated to cholera toxin or fragments thereof
#25287Methods of treating carcinoma using anti-TNF antibodies and peptides
#25288Methods of preventing adhesions following laminectomies and other surgical procedures
#25289Methods and compositions for treating rheumatoid arthritis
#25290Treatment for diabetic microvascular and macrovascular complications
#25291Gamma-tocopherol treatment for cystic fibrosis
#25292Alpha-tocopherol treatment for cystic fibrosis
#25293Coenzyme Q10 treatment for cystic fibrosis
#25294Methods of attenuating autoimmune disease and compositions useful therefor
#25295Compositions and methods for augmenting kidney function
#25296Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection
#25297Adjuvant agent for hepatitis C
#25298Method for delivering polymerized therapeutic agent compositions and compositions thereof
#25299Irrigating fluid
#25300Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
#2530111-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
#25302Methods and compositions for inhibiting the proliferation of prostate cancer cells
#25303Pharmaceutical compositions and method of using levodopa and carbidopa
#25304Inhibition of exoprotein production using isoprenoid compositions
#25305Use of angiotensin II receptor antagonists
#25306Xanthone derivatives, method of production thereof, and pharmaceutical composition containing the same
#25307Compositions containing a serotonin selective reuptake inhibitor and a 5-HT2A receptor antagonist
#25308Alkyne-aryl phosphodiesterase-4 inhibitors
#25309Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors
#25310Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes
#25311Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ACE inhibitor for the treatment of central nervous system damage
#25312Use of dihydroimidazolones for the treatment of dogs
#25313Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
#25314As-needed administration of an androgenic agent to enhance female desire and responsiveness
#25315Pharmaceutical composition and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist
#25316Substituted tetracycline compounds as synergistic antifungal agents
#25317Enteral formulation
#25318Use of dsrnas in strategic therapeutic intervention of highly active antiretroviral therapy
#25319Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
#25320Compositions for treatment and prevention of pulmonary conditions
#25321Antitumor agent
#25322Assay methods and amelioration of muscular dystrophy symptoms
#25323Novel complementing receptor-ligand pairs and adoptive immunotherapy using the same
#25324Methods for treating disorders using plant extracts
#25325Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of alprostadil for the treatment of female sexual dysfunction
#25326Compositions and methods comprising kava and anti-anxiety compounds
#25327Nitric oxide in treatment of inflammation
#25328Nutritional supplement containing 7-Keto-DHEA and conjugated linoleic acid
#25329Diphenhydramine tannate solid dose compositions and methods of use
#25330Compositions
#25331Compositions containing both sedative and non-sedative antihistamines and sleep aids
#25332Thiosemicarbazones as anti-virals and immunopotentiators
#25333Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
#25334Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
#25335Promoting Recovery from Damage to the Central Nervous System
#25336Combination pharmaceutical agents as inhibitors of HCV replication
#25337Methods and compositions for treating mammalian nerve tissue injuries
#25338Method for treating occlusive vascular diseases & wound healing
#25339Orally administrable composition for the photoprotection of the skin
#25340Combination method for treating viral infections
#25341Methods for Alzheimer's disease treatment and cognitive enhance
#25342Use of sulphonamide derivatives for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion
#25343Azole compound and medicinal use thereof
#25344Methods and compositions for treating rheumatoid arthritis
#25345Comprehensive pharmacologic therapy for treatment of obesity including cysteine
#25346Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a growth hormone secretagogue
#25347Combinations
#25348Treatment of sexual dysfunction
#25349Treatment of migraine accompanied by nausea with a combination of cyclooxygenase-2 selective inhibitors and anti-nausea agents
#253501-Adamantyl chalcones for the treatment of proliferative disorders
#25351Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an EP2 or EP4 selective agonist
#25352Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a cyclooxgenase-2 inhibitor
#25353Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and aromatase inhibitors
#25354Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters
#25355Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate
#25356Therapeutical treatment with oligo-beta- (1,3) -glucans, drugs used in said treatment
#25357Chemotherapeutic antineoplastic treatment
#25358Pharmaceutically active uridine esters
#25359Use of telmisartan for the prevention and treatment of vascular headache
#25360Stabilized ocular solutions
#25361TGF-beta activation and use
#25362Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone
#25363Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bone morphogenetic protein
#25364Methods and compositions for the treatment of motor neuron injury and neuropathy
#25365Stabilised insulin compositions
#25366Interleukin-18 binding proteins, their preparation and use
#25367Glycoprotein and process for producing the same
#25368Beverage compositions for use in rehydration and nutrition during athletic exercise and methods of making same
#25369Oral Rinse
#25370Composition and method for treating skin disorders
#25371Colon cleansing composition and method
#25372Cartilage implant plug with fibrin glue and method for implantation
#25373Dosage form, device, and methods of treatment
#25374Combination contraceptive, kits that contain the latter, and a method that uses the latter
#25375Pharmaceutical compositions containing plasma protein
#25376Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers
#25377Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same
#25378Ocular solutions
#25379Ocular solutions
#25380Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen
#25381Compositons and methods for weight loss
#25382Combination therapy for treating disease
#25383Systemic viral/ligand gene delivery system and gene therapy
#25384Method for treating cancer in humans
#25385Method of inducing maturation of dendritic cells and uses therefor
#25386Skin care compositions including hexapeptide complexes and methods of their manufacture
#25387Oral dosage form comprising a therapeutic agent and an adverse-effect agent
#25388Combined use of cruciferous indoles and chelators for the treatment of papilloma virus-related conditions
#25389Treatment of humans with colloidal silver composition
#25390Prevention and treatment of amyloidogenic disease
#25391Antiviral therapy
#25392Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
#25393Methods for treating mild cognitive impairment and alzheimer's disease
#25394Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1
#25395Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
#25396Compositions comprising inhibitors of IMPDH enzyme
#25397Medicinal compositions for the prevention or treatment of cardiac failure
#25398Methods of using zonisamide as an adjunctive therapy for partial seizures
#25399Combinations comprising alpha-2-delta ligands
#25400Treatment of diabetes with thiazolidinedione and metformin
#25401Compositions useful for treating gastrointestinal motility disorders
#25402Diaryl ureas for diseases mediated by PDGFR
#25403Combination of organic compounds
#25404Method of treating acute pain with a unitary dosage form comprising ibuprofen and oxycodone
#25405Use of tyrosine kinase inhibitors for treating inflammatory diseases
#25406Compositions and methods for treatment of cancer
#25407Method of treating middle ear infections
#25408CCR5 antagonists useful for treating AIDS
#25409Novel combination
#25410Method for treatment of depression and anxiety disorders by combination therapy
#25411Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
#25412Dermatological compositions and methods
#25413Medicaments for inhalation comprising a steroid and a betamimetic
#25414Compositions and methods for treating and preventing cancer using analogs of vitamin D
#25415Treatment for reactive arthritis or bursitis
#25416Per-6-substituted-per-6-deoxy-cyclodextrins, and use of the same to inhibit soluble beta-amyloid-peptide derived oligomers and to treat alzheimer's and related diseases
#25417Application of mRNA for use as a therapeutic agent for tumorous diseases
#25418Promoter driven tissue specific cytotoxic agents and title methods of use
#25419Therapeutic methods and compositions involving isoflavones
#25420Exendins, exendin agonists, and methods for their use
#25421Methods and compositions for producing a neurosalutary effect in a subject
#25422Prevention and treatment of amyloidogenic disease
#25423Methods and compositions for treating allergic reactions
#25424Dietary and pharmaceutical compositions for management and treatment of oxidative stress
#25425Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents
#25426Methods, compositions, and kits for organ protection during systemic anticancer therapy
#25427PSCA: prostate stem cell antigen and uses thereof
#25428Administration of capsaicinoids
#25429Herbal pharmaceutical composition for treating siriasis and its process
#25430Antimicrobial composition comprising soy oil, rice bran oil and jojoba oil
#25431Compositions and methods for preventing or treating eyestrain
#25432Treatment for bacterial infections and related disorders
#25433Cytokine modulators and related method of use
#25434Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent
#25435Fluid therapy with l-lactate and/or pyruvate anions
#25436Herbo-mineral formulation for refractory leukemias and lymphomas
#25437Methods and compositions for the treatment of angiogenic diseases
#25438Preparations for cigarette toxicity reduction, health enhancement, and addiction elimination
#25439Compositions capable of facilitating penetration across a biological barrier
#25440Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
#25441Antimicrobial compositions and methods
#25442Baby Care Skin Protectant Compositions for Diaper Rash
#25443Dietary supplement and method for treating digestive system-related disorders
#25444Combination therapy of gamma-interferon and B-cell specific antibodies
#25445Tolerance induction and maintenance in hematopoietic stem cell allografts
#25446Medicament against thrombotic diseases
#25447Nuclear reprogramming of cells for therapeutic use
#25448Chimeric IL-10 proteins and uses thereof
#25449Use of gp130 activators in diabetic neuropathy
#25450Methods of using Flt3-Ligand in hematopoietic cell transplantation procedures incorporating nonmyeloablative conditioning regimens
#25451Thymosin augmentation of genetic immunization
#25452Multi-system therapy for diabetes, the metabolic syndrome and obesity
#25453Immunoregulatory compounds and derivatives and methods of treating diseases therewith
#25454Phenyl naphthol ligands for thyroid hormone receptor
#25455Method for the treatment of glaucoma and ocular hypertension with prostaglandin analogues without melanogenic side effect
#25456Dimeric compounds and their use as anti-viral agents
#25457Dimeric compounds and their use as anti-viral agents
#25458Combinations of drugs for the treatment of neoplasms
#25459Method of controlling allergens
#25460Treatment of diabetes with thiazolidinedione and sulphonylurea
#25461Pharmaceutical composition
#25462Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
#25463Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
#25464Quinolinone derivatives
#25465Treatment for CD5+ B cell lymphoma
#25466GSK-3 inhibitors
#25467Compositions and methods for the treatment of disease associated with Trp-p8 expression
#25468New pharmaceutical combination
#25469Compositions of a cyclooxygenase-2 selective inhibitor and an antioxidant agent for the treatment of central nervous system disorders
#25470Method for treating erectile dysfunction and increasing libido in men
#25471Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
#25472Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
#25473Method for prevention of neuropsychiatric disorders
#25474Modified protein kinase a-specific oligonucleotides and methods of their use
#25475Methods for particle-assisted polynucleotide immunization using a pulsed electric field
#25476Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics
#25477Methods and compositions for the treatment of asthma and related disorders
#25478Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases
#25479Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator
#25480Use of sugar phosphates, sugar phosphate analog, amino acids, amino acid analogs for modulating transaminases and/or the association of p36/ malate dehydrogenase
#25481Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
#25482Angiogenesis-modulating compositions and uses
#25483Methods and compositions for treating ocular disorders
#25484Compositions for delivering parathyroid hormone and calcitonin
#25485Antiphlogistic agent and the use thereof
#25486Pediculicidal compound
#25487Methods and compositions for betel nut chewing gum
#25488Powdered composition for use as laxative
#25489Method of making, and the use of cytotoxic agents containing elemental selenium
#25490Pharmaceutical composition and method for retardation of the progression of atherosclerosis
#25491Composition and method for facilitating bone healing
#25492Composition for easing human childbirth
#25493Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
#25494Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
#25495Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
#25496Method of treating irritable bowel syndrome
#25497Method of treating viral infections
#25498Composition and method for providing temporary relief of sinus pain and nasal congestion
#25499Prevention and treatment of amyloidogenic disease
#25500Enhanced immunization and suppression of oral tolerance